H
HCW Biologics Inc. (HCWB)
NCM – Real Time Price. Currency in USD
1.03
-0.09 (-8.04%)
At close: Jun 26, 2026, 4:00 PM EDT
1.02
-0.01 (-0.97%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
1.03
-0.09 (-8.04%)
At close: Jun 26, 2026, 4:00 PM EDT
1.02
-0.01 (-0.97%)
After-hours: Jun 26, 2026, 7:58 PM EDT
No Data
There are no news for this stock.
Total debt $6.6M significantly exceeds cash reserves ($1.2M), raising financial stability concerns
Total current liabilities $20.0M surpass Total current assets $1.7M, signaling liquidity issues
Debt-to-equity ratio (1.1) is near the industry average, reflecting balanced leverage
Interest coverage ratio (30x) indicates the company easily manages its debt payments
Negative free cash flow -$1.6M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.09 | 6.05 | 1.0 | |
| Quick ratio | 0.09 | 5.63 | 1.0 | |
| Debt to Equity | 1.14 | 0.30 | 6.0 | |
| Debt to Assets | 0.24 | 1.04 | 7.0 | |
| Interest coverage | 29.67 | -16.91 | 10 | |
| Weighted average score | 5.0 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 7M | 3M | 3M | 54K | 7M |
| Gross Profit | 2M | -575K | -225K | -1M | 6M |
| Operating Income | -15M | -26M | -12M | -13M | -6M |
| Net Income | -15M | -25M | -30M | -22M | -18M |
| EBITDA | -14M | -25M | -11M | -12M | -5M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 95.14 | 5.5 |
| Next quarter | N/A | 95.64 | 5.5 |
| Current year | 11964.83 | 95.48 | 10 |
| Next year | 415.51 | 8.33 | 8.0 |
| Weighted average score | 7.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 24124.37 | 157.24 | 136.27 | 53.06 | 10 |
| Y/Y | 129080.67 | 190.31 | 118.5 | 55.17 | 10 |
| 3y average | -55.08 | -20.69 | -3.71 | 6.04 | 2.0 |
| 5y average | 146.75 | -39.91 | 7.52 | -14.61 | 4.5 |
| Weighted average score | 6.6 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |